CDSCO Panel Approves Novartis Protocol Amendment Proposal For Multiple Sclerosis Drug Ofatumumab Dr. Divya Colin11 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Study Safety and Efficacy of Tenecteplase 0.25 mg/kg in Acute Ischemic Stroke: CDSCO Panel Tells Boehringer Ingelheim Dr. Divya Colin10 Feb 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Boehringer Ingelheim's request for waiver of the local clinical trial of Metalyse 25 mg (tenecteplase 0.25 mg/kg)...
Indiscreet prescribing of antibiotics is key contributor to microbial resistance nationwide: MoS Health Ruchika Sharma9 Feb 2024 8:36 PM ISTNew Delhi: The Union Health Ministry has initiated several initiatives to promote judicious use of antimicrobials, as indiscreet prescribing of...
Submit Animal Toxicity Study Report: CDSCO Panel Tells Lupin on Parkinsonism FDC drug Dr. Divya Colin9 Feb 2024 6:00 PM ISTNew Delhi: Noting that the proposed dose is higher than the approved dose, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct India-specific Trial: CDSCO Panel Tells Roche on Satralizumab to Treat neuromyelitisoptica spectrum disorders Dr. Divya Colin8 Feb 2024 6:00 PM ISTNew Delhi: With an aim to establish the safety and efficacy of the Monoclonal Antibody Satralizumab in Indian patients, the Subject Expert Committee...
CDSCO Panel Grants Bristol-Myers Squibb's Protocol Amendment proposal for Mavacamten Dr. Divya Colin7 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
Synokem gets CDSCO Panel nod to study FDC Torsemide plus Eplerenone film coated tablet Dr. Divya Colin6 Feb 2024 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) report of the fixed-dose combination (FDC) Torsemide IP 10mg/ 20mg plus Eplerenone IP 25mg/25mg...
CDSCO Panel grants Intas Package Insert update for Pegfilgrastim solution for injection 6mg/0.6mL vial and PFS Dr. Divya Colin5 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Center Drug Standard Control Organisation (CDSCO) has approved drug major Intas...
CDSCO Panel grants Novartis Protocol Amendment proposal for Remibrutinib study in Relapsing Multiple Sclerosis Dr. Divya Colin5 Feb 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Windlass Biotech gets CDSCO Panel Nod To Manufacture, Market Ezetimibe plus Atorvastatin Calcium tablet Dr. Divya Colin4 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Windlas Biotech, the Subject Expert Committee (SEC) functional under the Central...
CDSCO Panel Approves Roche's Protocol Amendment Proposal for Anticancer Drug Giredestrant Dr. Divya Colin4 Feb 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
